Active Hemostatic Agents Market is expected to reach US$ 6.61 Bn. at a CAGR of 6.1% during the forecast period 2029.Active Hemostatic Agents Market Definition
The Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research. The report covers the current estimated and forecasted data for the Global Active Hemostatic Agents Market on a global and regional level. The report provides an in-depth analysis of the Global Active Hemostatic Agents Market for the period 2022 – 2029, wherein 2021 is the base year and the period from 2023 to 2029 is the forecast period. The Global Active Hemostatic Agents Market is segmented by Product, End-Use and Region. The report provides qualitative and quantitative insights on the market industry trends and a detailed analysis of the market size and growth rate of all segments in the market.To know about the Research Methodology :- Request Free Sample Report
Active Hemostatic Agents Market Dynamics
Hemorrhage occurring during and after surgery still remains one of the biggest problems in medicine. Uncontrolled hemorrhage remains one of the most significant causes of mortality in patients with traumas of various etymologies and medical conditions. There are a variety of methods available to reduce bleeding time & amount of blood loss. Hence, the use of active hemostatic agent’s remains the most popular and common way due to its simplicity, efficiency and ease of application. Mechanical and active topical sealant and hemostatic agents are now widely available in several forms. Applications of active hemostatic agents in the improvement of one of the most difficult cardiovascular procedures and repair of acute aortic dissection are the major factor driving the global market. Continuously ongoing research & development activities on the potential of new hemostatic agents led to give the lucrative opportunity for the global market. Improvements in the efficacy of these hemostatic agents, as well as delivery systems and product safety, will make these agents even better and more widely accepted.Segment Analysis
Thrombin based hemostat product is widely used by surgeons during various surgical procedures. Recently a recombinant thrombin based hemostat has been developed and approved for use by the Food Drug Administration. It has the advantage of being minimally antigenic and devoid of the risk of viral transmission. Thrombin based hemostat has grown exponentially, and now thrombin is used in more than 1 million patients in the United States each year at a cost of US$250 million. Recently there have been new developments in thrombin and FDA approvals in human thrombin commended the largest share xx% of the segment. The growing roles of thrombin based hemostat in hemostasis, inflammation and cell signalling are driving the global market. The hospital segment commanded the largest market share of xx% in the global market. Effective management in operating procedures for positive outcomes in the surgeries is boosting the global market. Continuing education activity to educate perioperative registered nurses (RNs) about the effective management of hemostasis in the surgical patient. Various methods available for control of bleeding during surgery are driving the global market.Regional Analysis
North America dominates the global active hemostatic agents market and it is expected to maintain its position in the forecast period. The high prevalence of cardiovascular disease and higher adoption of active hemostatic agents are anticipated to show growth in this region. Development in the public healthcare environment and the increasing prevalence of surgical procedures are showing growth for the global market. The objective of the report is to present a comprehensive analysis of the global active hemostatic agents market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. Surgical sealants as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global active hemostatic agents market dynamics, structure by analyzing the market segments and projects the global market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.Active Hemostatic Agents Market Key Highlights
Global active hemostatic agents market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the global market. Global active hemostatic agents market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. The Global active hemostatic agents market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global active hemostatic agents market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global active hemostatic agents market are also profiled.Active Hemostatic Agents Market Report Scope: Inquire before buying
Active Hemostatic Agents Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.36 Bn. Forecast Period 2023 to 2029 CAGR: 6.1% Market Size in 2029: US $ 6.61 Bn. Segments Covered: by Product Thrombin based hemostats Surgical sealants Combination Products by End-User Hospitals Ambulatory Surgical Centers Specialty Clinics by Type Active agent Passive Agent Combination by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Active Hemostatic Agents Market, Key Players are:
1. Medtronic Plc. 2. Ethicon Inc. 3. Pfizer Inc. 4. Baxter International Inc. 5. CryoLife Inc. 6. Integra Life Sciences Corporation, etc. 7. Stryker 8. Cryolife Inc 9. Biom’up 10.BD 11.Johnson & Johnson Services 12.C.R.Bard 13.B. Braun Melsungen AG 14.Z-Medica LLC 15.Advanced Medical Solutions Group plc 16.GELITA GA 17.Active Hemostatic Agents 18.Warrior Tactical, LLC Frequently Asked Questions: 1. Which region has the largest share in Global Active Hemostatic Agents Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Active Hemostatic Agents Market? Ans: The global market is growing at a CAGR of 6.1% during forecasting period 2023-2029. 3. What is scope of the global market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Active Hemostatic Agents Market? Ans: The important key players in the global market are – Medtronic Plc., Ethicon Inc., Pfizer Inc., Baxter International Inc., CryoLife Inc., Integra Life Sciences Corporation, etc., Stryker, Cryolife Inc, Biom’up, BD, Johnson & Johnson Services, C.R.Bard, B. Braun Melsungen AG, Z-Medica LLC, Advanced Medical Solutions Group plc, GELITA GA, Active Hemostatic Agents, Warrior Tactical, and LLC 5. What is the study period of this Market? Ans: The Global Active Hemostatic Agents Market is studied from 2022 to 2029.
1. Active Hemostatic Agents Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Active Hemostatic Agents Market: Dynamics 2.1. Active Hemostatic Agents Market Trends by Region 2.1.1. North America Active Hemostatic Agents Market Trends 2.1.2. Europe Active Hemostatic Agents Market Trends 2.1.3. Asia Pacific Active Hemostatic Agents Market Trends 2.1.4. Middle East and Africa Active Hemostatic Agents Market Trends 2.1.5. South America Active Hemostatic Agents Market Trends 2.2. Active Hemostatic Agents Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Active Hemostatic Agents Market Drivers 2.2.1.2. North America Active Hemostatic Agents Market Restraints 2.2.1.3. North America Active Hemostatic Agents Market Opportunities 2.2.1.4. North America Active Hemostatic Agents Market Challenges 2.2.2. Europe 2.2.2.1. Europe Active Hemostatic Agents Market Drivers 2.2.2.2. Europe Active Hemostatic Agents Market Restraints 2.2.2.3. Europe Active Hemostatic Agents Market Opportunities 2.2.2.4. Europe Active Hemostatic Agents Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Active Hemostatic Agents Market Drivers 2.2.3.2. Asia Pacific Active Hemostatic Agents Market Restraints 2.2.3.3. Asia Pacific Active Hemostatic Agents Market Opportunities 2.2.3.4. Asia Pacific Active Hemostatic Agents Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Active Hemostatic Agents Market Drivers 2.2.4.2. Middle East and Africa Active Hemostatic Agents Market Restraints 2.2.4.3. Middle East and Africa Active Hemostatic Agents Market Opportunities 2.2.4.4. Middle East and Africa Active Hemostatic Agents Market Challenges 2.2.5. South America 2.2.5.1. South America Active Hemostatic Agents Market Drivers 2.2.5.2. South America Active Hemostatic Agents Market Restraints 2.2.5.3. South America Active Hemostatic Agents Market Opportunities 2.2.5.4. South America Active Hemostatic Agents Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Active Hemostatic Agents Industry 2.8. Analysis of Government Schemes and Initiatives For Active Hemostatic Agents Industry 2.9. Active Hemostatic Agents Market Trade Analysis 2.10. The Global Pandemic Impact on Active Hemostatic Agents Market 3. Active Hemostatic Agents Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 3.1.1. Thrombin based hemostats 3.1.2. Surgical sealants 3.1.3. Combination Products 3.2. Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 3.2.1. Hospitals 3.2.2. Ambulatory Surgical Centers 3.2.3. Specialty Clinics 3.3. Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 3.3.1. Active agent 3.3.2. Passive Agent 3.3.3. Combination 3.4. Active Hemostatic Agents Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Active Hemostatic Agents Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 4.1.1. Thrombin based hemostats 4.1.2. Surgical sealants 4.1.3. Combination Products 4.2. North America Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 4.2.1. Hospitals 4.2.2. Ambulatory Surgical Centers 4.2.3. Specialty Clinics 4.3. North America Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 4.3.1. Active agent 4.3.2. Passive Agent 4.3.3. Combination 4.4. North America Active Hemostatic Agents Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 4.4.1.1.1. Thrombin based hemostats 4.4.1.1.2. Surgical sealants 4.4.1.1.3. Combination Products 4.4.1.2. United States Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 4.4.1.2.1. Hospitals 4.4.1.2.2. Ambulatory Surgical Centers 4.4.1.2.3. Specialty Clinics 4.4.1.3. United States Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 4.4.1.3.1. Active agent 4.4.1.3.2. Passive Agent 4.4.1.3.3. Combination 4.4.2. Canada 4.4.2.1. Canada Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 4.4.2.1.1. Thrombin based hemostats 4.4.2.1.2. Surgical sealants 4.4.2.1.3. Combination Products 4.4.2.2. Canada Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 4.4.2.2.1. Hospitals 4.4.2.2.2. Ambulatory Surgical Centers 4.4.2.2.3. Specialty Clinics 4.4.2.3. Canada Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 4.4.2.3.1. Active agent 4.4.2.3.2. Passive Agent 4.4.2.3.3. Combination 4.4.3. Mexico 4.4.3.1. Mexico Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 4.4.3.1.1. Thrombin based hemostats 4.4.3.1.2. Surgical sealants 4.4.3.1.3. Combination Products 4.4.3.2. Mexico Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 4.4.3.2.1. Hospitals 4.4.3.2.2. Ambulatory Surgical Centers 4.4.3.2.3. Specialty Clinics 4.4.3.3. Mexico Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 4.4.3.3.1. Active agent 4.4.3.3.2. Passive Agent 4.4.3.3.3. Combination 5. Europe Active Hemostatic Agents Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.2. Europe Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.3. Europe Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 5.4. Europe Active Hemostatic Agents Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.1.2. United Kingdom Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.1.3. United Kingdom Active Hemostatic Agents Market Size and Forecast, by Type(2022-2029) 5.4.2. France 5.4.2.1. France Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.2.2. France Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.2.3. France Active Hemostatic Agents Market Size and Forecast, by Type(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.3.2. Germany Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.3.3. Germany Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.4.2. Italy Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.4.3. Italy Active Hemostatic Agents Market Size and Forecast, by Type(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.5.2. Spain Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.5.3. Spain Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.6.2. Sweden Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.6.3. Sweden Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.7.2. Austria Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.7.3. Austria Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 5.4.8.2. Rest of Europe Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 5.4.8.3. Rest of Europe Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6. Asia Pacific Active Hemostatic Agents Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.2. Asia Pacific Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.3. Asia Pacific Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4. Asia Pacific Active Hemostatic Agents Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.1.2. China Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.1.3. China Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.2.2. S Korea Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.2.3. S Korea Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.3.2. Japan Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.3.3. Japan Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.4. India 6.4.4.1. India Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.4.2. India Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.4.3. India Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.5.2. Australia Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.5.3. Australia Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.6.2. Indonesia Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.6.3. Indonesia Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.7.2. Malaysia Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.7.3. Malaysia Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.8.2. Vietnam Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.8.3. Vietnam Active Hemostatic Agents Market Size and Forecast, by Type(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.9.2. Taiwan Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.9.3. Taiwan Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 6.4.10.2. Rest of Asia Pacific Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 6.4.10.3. Rest of Asia Pacific Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 7. Middle East and Africa Active Hemostatic Agents Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 7.2. Middle East and Africa Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 7.3. Middle East and Africa Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 7.4. Middle East and Africa Active Hemostatic Agents Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 7.4.1.2. South Africa Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 7.4.1.3. South Africa Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 7.4.2.2. GCC Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 7.4.2.3. GCC Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 7.4.3.2. Nigeria Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 7.4.3.3. Nigeria Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 7.4.4.2. Rest of ME&A Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 7.4.4.3. Rest of ME&A Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 8. South America Active Hemostatic Agents Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 8.2. South America Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 8.3. South America Active Hemostatic Agents Market Size and Forecast, by Type(2022-2029) 8.4. South America Active Hemostatic Agents Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 8.4.1.2. Brazil Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 8.4.1.3. Brazil Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 8.4.2.2. Argentina Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 8.4.2.3. Argentina Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Active Hemostatic Agents Market Size and Forecast, by Product (2022-2029) 8.4.3.2. Rest Of South America Active Hemostatic Agents Market Size and Forecast, by End User (2022-2029) 8.4.3.3. Rest Of South America Active Hemostatic Agents Market Size and Forecast, by Type (2022-2029) 9. Global Active Hemostatic Agents Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Active Hemostatic Agents Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Medtronic Plc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Ethicon Inc. 10.3. Pfizer Inc. 10.4. Baxter International Inc. 10.5. CryoLife Inc. 10.6. Integra Life Sciences Corporation, etc. 10.7. Stryker 10.8. Cryolife Inc 10.9. Biom’up 10.10. BD 10.11. Johnson & Johnson Services 10.12. C.R.Bard 10.13. B. Braun Melsungen AG 10.14. Z-Medica LLC 10.15. Advanced Medical Solutions Group plc 10.16. GELITA GA 10.17. Active Hemostatic Agents 10.18. Warrior Tactical, LLC 11. Key Findings 12. Industry Recommendations 13. Active Hemostatic Agents Market: Research Methodology 14. Terms and Glossary